Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient

World Allergy Organization Journal

Mary Keogan²  Colm Magee³  Fidelma Fitzpatrick¹  Ren Yik Lim³  Shanti Mahabir² 

[1] Health Protection Surveillance Centre, Dublin, Ireland;Immunology Department, Beaumont Hospital, Dublin 9, Ireland;Department of Renal Medicine, Beaumont Hospital, Dublin 9, Ireland

关键词: Clostridium difficile;    Vancomycin;    Desensitisation;    Anaphylaxis;    Allergy;   

Others  :  802828
DOI  :  10.1186/1939-4551-6-16

 received in 2012-11-14, accepted in 2013-05-30,  发布年份 2013

【 摘 要 】

The prevalence of Clostridium difficile infection (CDI) is increasing worldwide. Oral vancomycin is an effective and frequently used treatment. However, patients with CDI who are allergic to intravenous vancomycin cannot receive oral vancomycin due to the risk of anaphylaxis if given the oral form.

We present a case where oral vancomycin desensitisation was used to successfully treat a vancomycin allergic patient with recurrent CDI.

【 授权许可】

   
2013 Mahabir et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC: Epidemiology of recurrences or reinfections of Clostridium difficile associated diarrhoea. J Clin Microbiol 2000, 38:2386-2388.
• [2]Kuijper EJ, Coignard B, Tull P: Emergence of Clostridium difficile associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(suppl 6):2-18.
• [3]Zar FA, Bakkanagari SR, Moorthi KM, Davis MB: A comparison of vancomycin and metronidazole for the Treatment of Clostridium Difficile – Associated Diarrhoea, Stratified by Disease Severity. Clin Infect Dis 2007, 45:302-307.
• [4]Clostridium difficile subcommittee: Surveillance, Diagnosis and Management of C. Difficile-Associated Disease in Ireland. Dublin: Health Protection Surveillance Centre; 2008.
• [5]Armstrong CJ, Wilson TS: Systemic Absorption of Vancomycin. J Clin Pathol 1995, 48:689-692.
• [6]Aradhyula S, Manian FA, Hafidh SA, Bhutto SS, Alpert MA: Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function. South Med J 2006, 99(5):518-520.
• [7]Kitazawa T, Ota Y, Kada N, Morisawa Y, Yoshida A, Koike K, Kimura S: Successful Vancomycin Desensitization with a Combination of Rapid and Slow Infusion Methods. Intern Med 2006, 45(5):317-321.
• [8]Castells M: Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 2006, 6(6):476-481.
• [9]Wong JT, Ripple RF, MacLean JA, Marks DR, Bloch KJ: Vancomycin hypersensitivity: Synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol. J Allergy Clin Immunol 1994, 94(2 pt 1):189-194.
• [10]Levy JH, Kettlekamp N, Goertz P, Hermens J, Hirshman C: Histamine release by Vancomycin : A Mechanism for Hypotension in Man. Anesthesiology 1987, 67(1):122-125.
• [11]Lobera T, Audicana MT, Pozo MD, Blasco A, Fernandez E, Canada P, Gastaminza G, Martinez–Albelda I, Gonzalez–Mahave I, Munoz D: Study of Hypersensitivity Reactions and Anaphylaxis in Spain. J Investig Clin Immunol 2008, 18(5):350-356.
• [12]Anne S, Middleton E Jr, Reisman RE: Vancomycin anaphylaxis and successful desensitization. Ann Allergy 1994, 73(5):402-404.